VCP ScannerFree US Stock Screener & Financial AnalysisFree US Stock Screener
ScreenerThemes
DCF ValuationCalculate intrinsic value of US stocks
Market ValuationBuffett indicator, CAPE & macro gauges
Total ReturnSee dividends + price return history
DCA CalculatorSimulate recurring buys & compounding
Earnings
FAANG & Tech
AAPL vs MSFTNVDA vs AMDGOOGL vs META
Cloud & Cyber
CRM vs NOWCRWD vs PANWSNOW vs DDOG
Consumer & Auto
TSLA vs FAMZN vs WMTNFLX vs DIS
Finance & Crypto
JPM vs BACV vs MACOIN vs MSTR
Pharma & Energy
LLY vs NVOJNJ vs PFEXOM vs CVX
Compare Any Stocks...
WatchlistInsider
ScreenerThemes
Earnings
WatchlistInsider
ANIKAnika Therapeutics, Inc.
$15.10$202M
Overview & Verdict
Overview
Valuation & Forecasts
Valuation ModelsEstimatesDCF Model
Price & Analyst Data
Analyst TargetsPrice HistoryTechnical Analysis
Financial Statements
Income StatementBalance SheetCash FlowRatios & Margins
Performance
P/E HistoryRevenue HistoryEarnings HistoryDividend HistoryTotal Return
Ownership
Holders
← Back to Screener
VCP ScannerFree US Stock Screener & Financial Analysis

Find stocks. Verify deeply. Act with conviction.

Data updated daily

Product

  • Screener
  • Themes
  • Valuation
  • Total Return
  • DCA Calculator
  • News
  • Earnings

Resources

  • Market Valuation
  • Compare
  • Insider Activity
  • Methodology
  • How It Works
  • Glossary
  • Learn

Get Ideas

Get weekly stock ideas — free

© 2026 VCP Scanner
AboutPrivacyTerms
Not financial advice. Do your own research.
ScreenerNewsCompareWatchlist
HomeStocksANIKCash Flow

Anika Therapeutics, Inc. (ANIK) Cash Flow Statement

30Y historyFree accessUpdated daily

Liquidity is under pressure as evidenced by a $6.3M free cash flow outflow in 2026Q1, exacerbated by $8.7M in share repurchases despite the company's ongoing cash-burning state.

ANIK Cash Flow Statement

Income StatementBalance SheetCash FlowRatios
AnnualQuarterly
MetricTTMDec'25Dec'24Dec'23Dec'22Dec'21Dec'20Dec'19Dec'18Dec'17Dec'16Dec'15Dec'14Dec'13Dec'12Dec'11Dec'10Dec'09Dec'08Dec'07Dec'06Dec'05Dec'04Dec'03Dec'02Dec'01Dec'00Dec'99Dec'98Dec'97Dec'96
Cash from Operations6.47M11.19M5.4M-1.79M4.41M8.4M13.06M37.01M34.92M40.81M23.8M39.06M39.98M25.16M10.55M10.17M7.85M3.09M3.41M4.49M2M6.45M23.82M2.01M332.03K-4.31M-1.88M800K3.4M2.6M-1.1M
Operating CF Margin %-9.92%4.51%-1.48%3.87%5.68%10.01%32.29%33.08%35.98%23.02%42%37.86%33.52%14.78%15.7%14.14%7.71%9.52%14.57%7.46%21.63%90.02%13.06%2.52%-38.14%-11.53%5.93%24.46%21.67%-91.67%
Operating CF Growth %-3315.3%107.07%402.18%-140.55%-47.49%-35.73%-64.69%5.98%-14.44%71.47%-39.07%-2.29%58.87%138.56%3.69%29.54%153.77%-9.17%-24.16%124.5%-68.98%-72.92%1084.1%505.97%107.7%-129.07%-335.43%-76.47%30.77%336.36%35.29%
Net Income-11.06M-10.88M-56.38M-82.67M-14.86M4.13M-23.98M27.19M18.72M31.82M32.55M30.76M38.32M20.57M11.76M8.47M4.32M3.69M3.63M6.04M4.6M5.89M11.19M827K-3.04M-6.76M173.55K1.1M4.3M3.3M-2.7M
Depreciation & Amortization5.54M5.73M8.12M14.22M14.49M14.32M14.99M5.99M5.91M4.29M3.73M3.77M4.71M4.77M4.53M4M3.32M1.29M1.43M818.73K384.06K459K710K1.01M1.1M1.23M1.2M1.1M800K300K600K
Stock-Based Compensation13.86M10.08M13.13M15.24M14.31M11.09M06.09M11.05M5.81M3.39M2.23M1.61M1.27M1.15M1.19M1.1M958.02K1.39M911.72M1.27B0000000000
Deferred Taxes83K-7K260K-6.33M-5.27M-1.77M-3.54M794K-1.82M-1.2M-712K-1.59M-8.81M1.35M-462.74K1.72M1.89M1.74M377.05K696.52K659.98K1.91M-11.18M00000000
Other Non-Cash Items7.79M7.08M53.37M69.87M7.56M-4.66M39.05M3.58M4.26M2.45M706K945K377.75K122.32K3.05M1.76M1M322.87K-117.88K-911.29M-1.27B1.21M652K-6K10K129K63K100K200K200K500K
Working Capital Changes-9.74M-823K-13.09M-12.12M-11.82M-14.72M-13.46M-6.64M-3.2M-2.36M-15.87M2.96M3.78M-2.92M-9.47M-6.96M-3.78M-4.9M-3.31M-3.49M-4.46M-3.02M22.45M185K2.27M1.08M-3.32M-1.5M-1.9M-1.2M500K
Change in Receivables-4.81M408K3.37M-1.3M-5.63M-6.22M5.86M-1.84M2.91M2.67M-6.2M-5M897.56K2.41M-4.27M-3M-3.72M-1.7M377.55K-2.29B-1.44B288M-933M-217M1.03B000000
Change in Inventory-5.9M30K-9.42M-11.4M-6.87M-6.62M-14.18M-5.58M-7.58M-6.52M-1.74M-2.94M-1.97M-2.82M-2.37M224.71K-1.22M-1.87M-1.27M850.55K-2.18M826K-642K-703K802.91K1.01M756.06K-2M-1M-100K0
Change in Payables740K42K-2.51M-11K1.97M-1.1M822K767K-1.67M3.89M-5.06M5.63M-749.6K622.93K-2.88M-6.59M5.78M141.08K-129.66K1.13B-312.6M486M442M-497M-109.1M000000
Cash from Investing-3.31M-401K-8.33M-5.43M-7.49M-3.12M-71.26M39.69M-50.26M-12.48M-6.76M-30.23M-8.3M-253.16K-1.5M-1.4M-2.68M-20.22M-12.8M-18.28M-1.31M-1.6M344K1.49M1.6M5.11M3.17M-3.7M-14.4M-400K0
Capital Expenditures-5.43M-6.83M-7.73M-5.43M-7.49M-5.14M-1.63M-2.83M-4.66M-8.98M-14.01M-9.22M-1.55M-440.89K-1.5M-1.4M-2.78M-3.96M-16.25M-14.76M-1.31M-1.6M-474K-256K-88.91K-908.47K-505.35K-1.7M-2.2M-300K0
CapEx % of Revenue4.67%6.05%6.45%4.49%6.58%3.48%1.25%2.47%4.41%7.92%13.56%9.92%1.47%0.59%2.11%2.16%5.01%9.87%45.41%47.86%4.87%5.36%1.79%1.66%0.67%8.03%3.09%12.59%15.83%2.5%-
Acquisitions4.5M8.99M000-476K-94.6M-42.52M000000000-16.26M0000000000000
Investments-------------------------------
Other Investing-2.38M-2.57M-600K000042.52M-45.6M-3.5M7.25M-21M-6.75M187.74K00105.3K0-58.06K-1B00818K-759K199.1K-23.56K-29K-5.8M-200K-100K0
Cash from Financing-15.46M-10.55M-12.73M-6.32M-4.85M-6.78M-3.77M-8.14M-28.9M314K-23.35M1.92M5.33M-5.69M-758.85K-1.17M-1.34M-1.64M16.69M2.53M1.73M556K579K93K00539.93K-1.4M-1M17.7M200K
Debt Issued (Net)0000-284K-201K-558K000000-9.6M-1.6M-1.6M-1.6M-1.6M15.91M000000000000
Equity Issued (Net)-13.7M-8.98M-10.91M-5M001.52M-30.29M-30M0-25M02.05M0000001.88M1.22M556K579K93K00539.93K-1.43M-900K17.7M200K
Dividends Paid0000000000000000000000000000000
Share Repurchases-14.2M-9.48M-10.91M-5M000-30M-30M0-25M00000016.82B000000000-1.95M-2M00
Other Financing-1.76M-1.57M-1.81M-1.32M-4.57M-6.58M-4.74M22.15M1.1M314K1.65M1.92M3.28M3.91M841.15K434.66K262.68K-43.5K775.13K643.35K505.93K0092.91M0000-100K00
Net Change in Cash-12.35M322K-15.71M-13.46M-8.06M-1.43M-61.65M68.42M-44.21M29M-6.45M10.55M36.82M19.27M8.29M7.58M3.77M-18.77M7.29M-11.26M2.42M5.41M24.75M3.59M1.94M799.04K1.83M-4.3M-12M19.9M-900K
Free Cash Flow1.04M4.36M-2.33M-7.21M-3.08M3.25M11.44M34.18M30.26M31.83M9.79M29.84M38.43M24.72M9.04M8.77M5.07M-867.53K-12.84M-10.26M695.37K4.85M23.35M1.76M243.12K-5.22M-2.39M-900K1.2M2.3M-1.1M
FCF Margin %0.89%3.87%-1.94%-5.97%-2.7%2.2%8.77%29.82%28.67%28.07%9.47%32.09%36.39%32.93%12.67%13.54%9.12%-2.16%-35.88%-33.29%2.59%16.26%88.23%11.4%1.84%-46.17%-14.62%-6.67%8.63%19.17%-91.67%
FCF Growth %126.3%287.13%67.69%-134.48%-194.56%-71.55%-66.54%12.94%-4.93%225.25%-67.2%-22.35%55.42%173.38%3.09%73.08%684.25%93.24%-25.1%-1575.88%-85.67%-79.22%1229.73%622.28%104.65%-118.64%-165.42%-175%-47.83%309.09%45%
FCF per Share0.080.30-0.16-0.49-0.210.220.802.382.062.110.651.952.521.670.630.640.37-0.08-1.12-0.900.060.422.040.160.02-0.53-0.24-0.090.110.31-0.23
FCF Conversion (FCF/Net Income)-0.09x-1.03x-0.10x0.02x-0.30x2.03x-0.54x1.36x1.87x1.28x0.73x1.27x1.04x1.22x0.90x1.20x1.82x0.84x0.94x0.74x0.43x1.09x2.13x2.43x-0.11x0.64x-10.85x-0.32x0.79x0.79x0.41x
Interest Paid0000000000000126K184.88K193.88K222.92K208.05K191.14K000000000000
Taxes Paid003.99M3.12M106K1.23M09.26M5.56M15.09M22.83M12.72M13.78M9.84M6.5M2.65M360K1.21M10K1.81M00000000000

Key Metrics

Growth RegimeMixed
ProfitabilityNegative
Balance SheetHealthy
Cash FlowBurning
Top Statement Risk

Persistent negative operating cash

Verified Source

Metrics are mathematically derived from official filings.

SEC 10-K (2026Q1)

Earnings Quality and Cash Disconnect

As reported in recent financial filings, the persistent divergence between net income and operating cash flow, highlighted by an OCF/NI ratio of 0.96 in 2026Q1, suggests that Anika's reported earnings are heavily influenced by non-cash adjustments rather than sustainable cash generation from core operations.

The frequent disconnect between accounting losses and cash flow outcomes indicates that the company's profitability metrics are not currently reflective of its underlying cash-generating capacity. Investors should monitor whether this trend persists, as the reliance on non-cash items to bridge the gap between net income and operating cash flow may mask deeper operational inefficiencies.

Free Cash Flow Volatility Trends

Based on quarterly data, Anika's free cash flow trajectory remains highly unstable, swinging from a $5.0M inflow in 2025Q3 to a $6.3M outflow in 2026Q1, which underscores the difficulty in achieving consistent cash flow positivity during the current strategic transition toward direct sales.

The erratic nature of free cash flow suggests that the company's capital allocation and operational spending are not yet synchronized with revenue cycles. This volatility warrants further investigation into whether the current cash burn is a temporary byproduct of investment or a structural feature of the new business model.

Working Capital Efficiency Remains Strained

According to the provided cash flow statements, working capital fluctuations have become a significant drag on liquidity, evidenced by a $9.2M outflow in 2026Q1, which suggests that the company is struggling to manage its inventory and receivables effectively during its commercial expansion phase.

The recurring negative impact of working capital changes on operating cash flow implies that the company may be tying up excessive capital in inventory or facing delays in collections. This trend appears to be a primary contributor to the company's current cash-burning status and requires closer scrutiny of the underlying inventory turnover metrics.

Capital Allocation Amidst Cash Burn

As indicated by recent financial statements, Anika continues to prioritize share repurchases, such as the $8.7M outflow in 2026Q1, despite generating negative free cash flow, which raises questions regarding the sustainability of returning capital to shareholders while the core business remains in a cash-burning state.

The decision to allocate significant cash to buybacks while operating cash flow is negative suggests a management focus on supporting the share price that may be at odds with the company's immediate liquidity needs. Investors should monitor whether this capital deployment strategy is prudent given the lack of consistent profitability and the ongoing need for investment in the direct sales force.

ANIK — Frequently Asked Questions

Quick answers to the most common questions about buying ANIK stock.

How much cash does Anika Therapeutics, Inc. (ANIK) generate from operations?

Anika Therapeutics, Inc. (ANIK) generated $11.2M in net cash from operating activities in 2025. This reflects the cash generated directly from core business operations.

What is Anika Therapeutics, Inc.'s free cash flow?

Anika Therapeutics, Inc. (ANIK) generated $4.4M in free cash flow in 2025. Free cash flow is the cash left over after capital expenditures, which can be used to pay dividends, repurchase shares, or pay down debt.

What is Anika Therapeutics, Inc.'s capital expenditure (CapEx)?

Anika Therapeutics, Inc. (ANIK) spent $6.8M on capital expenditures in 2025. CapEx represents the cash invested in physical assets like property, plant, and equipment to maintain or grow the business.

How does Anika Therapeutics, Inc. distribute cash to shareholders?

In 2025, Anika Therapeutics, Inc. (ANIK) spent $9.5M on share repurchases. This shows the company's commitment to returning capital to its equity investors.